Rense.com



Update On The Genetic
Engineering Experiments
On Animals
http://www.purefood.org/Patent/xgenicanimals.cfm
10-31-00
 
TRANSGENIC ANIMAL ROUNDUP
 
Germline engineering and cloning of mammals is underway at biotech companies and universities around the world. During the past few months, researchers in the US, Canada, the UK, Japan, and China have announced the birth of cloned or genetically modified (transgenic) goats, sheep, pigs, cows, mice, monkeys, and rabbits.
 
Some of this work is aimed at medical applications, including production of human proteins in the milk of transgenic animals, and xenotransplant- ation. Some is intended for strictly commercial uses: for example, more efficient production of meat or super-strong fibers. A collaboration between an artist and genetic scientists has produced a transgenic rabbit that glows in the dark for a museum exhibit. (See below.)
 
Skeptics have raised a variety of concerns about many of these intended applications and some of the methods used to produce transgenic animals. Areas of concern include threats to human health, animal welfare, and environmental integrity; the patenting of animals; further corporate concentration in our food systems; and ethical and cultural objections to the technological transformation of animals.
 
Focusing as we do on human genetic technologies, we note that many of the techniques being developed are similar to those that could be used for human germline engineering and reproductive cloning. We hope that the production of genetically altered mammals will not foster acceptance for genetically modified human beings.
 
1. Transgenic Goats May Secrete Spider Silk;
Cloned Goat Dies
 
One of Canada's leading animal transgenic companies, Nexia Biotechno- logies, announced in late August that it is "on the verge" of producing goats that secrete spiders' silk in their milk. The announcement came as Nexia prepared to breed two male transgenic goats with a herd of unmodified females. Nexia scientists expect the offspring to produce milk containing the spider silk protein, which Nexia will use to manufacture a material lighter and stronger than steel. Anticipated uses include "aircraft, racing vehicles and bullet-proof clothing," as well as "sutures for eye- or neurosurgery" and "artificial tendons, ligaments and limbs." See Lin k.
 
Nexia is being targeted by the Bioengineering Action Network of North America. See Link.
 
Two cloned goats were born in Xian, China in June, but one died after 36 hours because of abnormal lung development. The researchers expect the birth of a cloned ox before the end of the year. Chinese scientists say they want to use cloning to save endangered species such as the giant panda and the white flag freshwater dolphin. See Link.
 
 
2. New Method Sets Stage for Commercialization of Cow Cloning
 
At the end of August, University of Tennessee researchers announced the birth of the world's first cloned Jersey calf, the third cow cloned from adult cow cells. The other cloned cows were produced at Texas A&M and the University of Connecticut within the past year.
 
The Tennessee scientists described their method as a simplified version of the somatic cell nuclear transfer technique developed by the Roslin Institute. "We basically were able to use routine cell culture methods in the laboratory," which could make cloning on a commercial basis more affordable, said team leader Dr. Lannett Edwards. See Link.
 
 
3. First In Utero Gene Transfer in Monkeys
 
Researchers at Children's Hospital in Columbus, Ohio announced in May the transfer of foreign genes into rhesus macaques monkeys fetuses. The researchers injected 14 macaque fetuses with two retroviral vectors that carried a fluorescing marker gene derived from jellyfish. All the infants were reportedly healthy and normal, and expressed the fluorescing gene in every cell of their bodies for about a month. After that, the expression of the marker gene stopped. The lead researcher speculated that the monkeys may have mounted an immune response to the foreign protein. See Link
 
 
4. Gene Targeting Produces Transgenic Sheep
 
Scientists at PPL Therapeutics announced in the June 29 issue of Nature that they had produced two cloned sheep with a specific gene modification. Their method involved adding a human gene at a pre-selected location on the chromosomes of sheep cells, and then transferred the nuclei of those cells to enucleated sheep eggs. This was the first time such "gene targeting" methods had succeeded in any mammal besides mice.
 
With other methods of producing transgenic animals, the foreign genes are incorporated into the animal's genome at a random location. The results are unpredictable, and often disastrous for the developing animal. PPL research director Alan Colman called the ability to reliably control the genetic manipulation of mammals "a sort of the Holy Grail." See Link.
 
Following the announcement, PPL revealed that the human DNA they had inserted into the sheep was used without the knowledge of its donor. The disclosure was prompted by rumors that the DNA had come from the Maori community, many of whose members find genetic modification of animals "culturally offensive." In New Zealand, "fierce opposition" to PPL's work is also based on concerns about containing the transgenes in the experimental population. See Link< /A>.
 
 
5. New Methods for Cloning Pigs; New Evidence for Xenotransplantation Concerns
 
Two groups of researchers, one at the National Institute of Animal Industry in Japan and one at PPL Therapeutics, announced in August details of the methods they'd used to successfully clone pigs. Each method was a different variation on the somatic nuclear transfer technique developed at the Roslin Institute. See Lin k .
 
Researchers are eager to perfect the cloning of pigs, which has proven more difficult than in sheep, goats, or cows, because pig organs are the right size for "xenotransplantation" into humans. The pig organs would have to be genetically engineered so that they were not rejected by the human immune system.
 
The Campaign for Responsible Transplantation argues that xenotransplant- ation should be banned. CRT points to the threat of human epidemics that might be caused by porcine retroviruses, and describes other approaches could solve the organ shortage. A study at the Scripps Institute in La Jolla, California, published in August on the Nature magazine web site, provides new evidence that these safety concerns are well-founded. The Scripps researchers found that mice given pig tissue transplants became infected with pig viruses, as did human cells in culture with the pig retroviruses. See <www.crt-online.org and (additional) Link
 
Following the announcement of the Scripps findings, Geron BioMed, the California company that last year purchased the patent for the cloning technique developed at the Roslin Institute, withdrew its funding for the xenotransplantation project at PPL Therapeutics. Roslin also announced that it will stop its xenotransplantation work, but insists that this decision is based on "purely commercial" considerations. PPL has pledged to continue its xenotransplantation project. See <Link
and
http://dailynews.yahoo.com/h/nm/20000817/sc/pigs_dc_2.html.
 
Meanwhile, a Georgia biotech start-up, ProLinia, Inc., has drawn up a business plan for cloning livestock on a commercial basis when the technology is developed. ProLinia plans, for example, to sell farmers cloned pigs that will produce leaner bacon and meatier pork chops. According to the Washington Post (Terence Chea, "Going Whole Hog for Cloning," August 5, 2000), Smithfield Foods Inc., one of the world's largest pork producers, has invested $1 million in ProLinia on the basis of its cloning plans.
 
 
6. Jellyfish Genes in Rabbits: For Art's Sake?
 
Eduardo Kac, a professor at the School of the Art Institute of Chicago, has teamed up with French geneticists to produce a rabbit that glows in the dark by injecting rabbit zygotes with a fluorescent protein gene derived from jellyfish.
 
Kac has stirred controversy since he announced a plan to create a trans- genic dog at an Ars Electronica gathering in Austria last September (Lori Andrews, "Weird Science," Chicago, Aug 2000). Some other artists were appalled by the plan. "It's one thing for an artist to experiment on a canvas, but it's entirely different to experiment on a living creature," said Ellen Ullman, author of "Close to the Machine." Ullman pointed out that the harm isn't limited to the modified creature. "What does it do to a society to casually create fluorescent dogs?" (Tom Abate, "Artist Proposes Using Jellyfish Genes to Create Glow-in- the-Dark Dogs," San Francisco Chronicle, October 18, 1999.)
 
Many other artists are exploring biotechnology and its social meaning (without producing transgenic animals). A show called "Paradise Now: Picturing the Genetic Revolution" is at the Exit Art gallery in Manhattan from September 9 until October 28. An exhibit called "Unnatural Science" will be at MassMOCA until April 15, 2001. See <Link.
 
Other shows are planned at the Santa Barbara Museum of Art, the International Center of Photography in New York, and the University of Washington's Henry Art Gallery in Seattle. (Jordan Lite, "Artists Mine Genomic Issues," Wired News, May 13, 2000 http://www.wi red.com/news/print/0,1294,36288,000.html.)
 
 
 
 
Organic Consumers Association - http://www.purefood.org
Home 6101 Cliff Estate Rd.,
Little Marais, MN 55614,
Activist or Media Inquiries: (218) 226-4164,
Fax: (218) 226-4157



 
 
MainPage
http://www.rense.com
 
 
 
This Site Served by TheHostPros